Logo

American Heart Association

  21
  0


Final ID:

Leveraging the Get With The Guidelines (GWTG) Database for Research Innovation

  • Lewsey, Sabra  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Allen, Larry  ( UNIVERSITY COLORADO DENVER , Aurora , Colorado , United States )
  • Fanaroff, Alexander  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Berg, David  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Reading Turchioe, Meghan  ( Columbia University SON , New York , New York , United States )
  • Author Disclosures:
    Sabra Lewsey: DO NOT have relevant financial relationships | Larry Allen: DO have relevant financial relationships ; Consultant:ACI Clinical:Past (completed) ; Consultant:UpToDate:Active (exists now) ; Consultant:Quidel:Past (completed) | Alexander Fanaroff: DO have relevant financial relationships ; Research Funding (PI or named investigator):Prolocor:Past (completed) ; Consultant:JNJ/BMS:Expected (by end of conference) ; Research Funding (PI or named investigator):Optum:Active (exists now) ; Consultant:Abbott:Past (completed) ; Consultant:Novartis:Past (completed) | David Berg: DO have relevant financial relationships ; Research Funding (PI or named investigator):AstraZenea:Active (exists now) ; Other (please indicate in the box next to the company name):CEC - CeleCor Therapeutics:Active (exists now) ; Other (please indicate in the box next to the company name):CEC - Beckman Coulter:Active (exists now) ; Other (please indicate in the box next to the company name):CEC - Novo Nordisk:Active (exists now) ; Other (please indicate in the box next to the company name):CEC - Tosoh Biosciences:Active (exists now) ; Other (please indicate in the box next to the company name):CEC - Kowa Pharmaceuticals:Past (completed) ; Speaker:USV Private Limited:Past (completed) ; Speaker:Pri-Med:Past (completed) ; Speaker:Metabolic Endocrine Education Foundation:Past (completed) ; Consultant:Youngene Therapeutics:Past (completed) ; Consultant:Pfizer:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) ; Research Funding (PI or named investigator):Merck:Active (exists now) ; Research Funding (PI or named investigator):Pfizer:Active (exists now) | Meghan Reading Turchioe: DO have relevant financial relationships ; Ownership Interest:Iris OB Health:Active (exists now) ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Consultant:Boston Scientific:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Innovation in Quality – Get With The Guidelines Research

Sunday, 11/09/2025 , 09:45AM - 10:30AM

Special Focus

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available